HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC: Paying A Big-Name Beauty Influencer To Smear A Competitor Is Unlawful … In These Contexts

Executive Summary

Marketing insiders are denouncing the growing trend of beauty companies weaponing influencers against competing brands. Mary Engle, associate director of FTC’s Division of Advertising Practices, discusses the practice and lines that shouldn’t be crossed, blurry as they may well be.

You may also be interested in...



In Online Advertising Arena, Artificial Intelligence Aids And Abets Fake Reviews, False Claims

AI has a place in the FTC's proposed rule to ban fake consumer reviews and testimonials in online advertising in the US for a reason, one that BBB National Programs also acknowledges.

US FTC’s Final ‘Endorsement Guides’ Launch New Era In Online #Ad Regulation

The FTC’s final revised Guides Concerning the Use of Endorsements and Testimonials in Advertising address online practices that have grown increasingly prevalent and problematic since the commission last updated the guidelines in 2009. The FTC tackles deceptive product reviews and advises advertisers and endorsers to make social media disclosures “unavoidable,” among other changes.

Unfairly Hit By Influencer Assassins? Now Could Be Your Chance To Engage The FTC

Brands unfairly attacked by powerful influencers could raise the subject with the US Federal Trade Commission, which is asking for comments on its “Endorsement Guides."  

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148533

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel